Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China flag China · Delayed Price · Currency is CNY
73.87
-0.62 (-0.83%)
May 13, 2025, 2:45 PM CST

Xiamen Amoytop Biotech Statistics

Total Valuation

SHA:688278 has a market cap or net worth of CNY 30.30 billion. The enterprise value is 29.50 billion.

Market Cap 30.30B
Enterprise Value 29.50B

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date Aug 22, 2025
Ex-Dividend Date May 9, 2025

Share Statistics

SHA:688278 has 406.80 million shares outstanding. The number of shares has increased by 0.59% in one year.

Current Share Class 406.80M
Shares Outstanding 406.80M
Shares Change (YoY) +0.59%
Shares Change (QoQ) -0.89%
Owned by Insiders (%) 48.01%
Owned by Institutions (%) 10.35%
Float 126.10M

Valuation Ratios

The trailing PE ratio is 34.52 and the forward PE ratio is 25.71. SHA:688278's PEG ratio is 0.95.

PE Ratio 34.52
Forward PE 25.71
PS Ratio 10.29
PB Ratio 11.02
P/TBV Ratio 11.71
P/FCF Ratio 92.93
P/OCF Ratio 54.24
PEG Ratio 0.95
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.21, with an EV/FCF ratio of 90.48.

EV / Earnings 33.49
EV / Sales 10.02
EV / EBITDA 28.21
EV / EBIT 30.14
EV / FCF 90.48

Financial Position

The company has a current ratio of 5.56, with a Debt / Equity ratio of 0.01.

Current Ratio 5.56
Quick Ratio 4.47
Debt / Equity 0.01
Debt / EBITDA 0.02
Debt / FCF 0.06
Interest Coverage 2,145.18

Financial Efficiency

Return on equity (ROE) is 37.06% and return on invested capital (ROIC) is 25.59%.

Return on Equity (ROE) 37.06%
Return on Assets (ROA) 21.82%
Return on Invested Capital (ROIC) 25.59%
Return on Capital Employed (ROCE) 34.54%
Revenue Per Employee 1.22M
Profits Per Employee 363,567
Employee Count 2,423
Asset Turnover 1.05
Inventory Turnover 0.77

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +26.84% in the last 52 weeks. The beta is 0.09, so SHA:688278's price volatility has been lower than the market average.

Beta (5Y) 0.09
52-Week Price Change +26.84%
50-Day Moving Average 77.58
200-Day Moving Average 70.88
Relative Strength Index (RSI) 42.67
Average Volume (20 Days) 2,812,005

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHA:688278 had revenue of CNY 2.95 billion and earned 880.92 million in profits. Earnings per share was 2.16.

Revenue 2.95B
Gross Profit 2.75B
Operating Income 978.71M
Pretax Income 982.87M
Net Income 880.92M
EBITDA 1.04B
EBIT 978.71M
Earnings Per Share (EPS) 2.16
Full Income Statement

Balance Sheet

The company has 818.11 million in cash and 18.17 million in debt, giving a net cash position of 799.94 million or 1.97 per share.

Cash & Cash Equivalents 818.11M
Total Debt 18.17M
Net Cash 799.94M
Net Cash Per Share 1.97
Equity (Book Value) 2.75B
Book Value Per Share 6.76
Working Capital 1.57B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 558.71 million and capital expenditures -232.65 million, giving a free cash flow of 326.06 million.

Operating Cash Flow 558.71M
Capital Expenditures -232.65M
Free Cash Flow 326.06M
FCF Per Share 0.80
Full Cash Flow Statement

Margins

Gross margin is 93.46%, with operating and profit margins of 33.23% and 29.91%.

Gross Margin 93.46%
Operating Margin 33.23%
Pretax Margin 33.37%
Profit Margin 29.91%
EBITDA Margin 35.30%
EBIT Margin 33.23%
FCF Margin 11.07%

Dividends & Yields

This stock pays an annual dividend of 0.62, which amounts to a dividend yield of 0.83%.

Dividend Per Share 0.62
Dividend Yield 0.83%
Dividend Growth (YoY) 51.22%
Years of Dividend Growth 5
Payout Ratio 18.95%
Buyback Yield -0.59%
Shareholder Yield 0.25%
Earnings Yield 2.91%
FCF Yield 1.08%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SHA:688278 has an Altman Z-Score of 41.23.

Altman Z-Score 41.23
Piotroski F-Score n/a